{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:02:51Z","timestamp":1794888171952,"version":"4.9.1"},"reference-count":37,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2026,7,3]]},"DOI":"10.1080\/14737140.2026.2623059","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:27:24Z","timestamp":1770272844000},"page":"797-807","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting\n                    <i>HER2<\/i>\n                    -mutant NSCLC: a bench-to-bedside review"],"prefix":"10.1080","volume":"26","author":[{"given":"John V.","family":"Heymach","sequence":"first","affiliation":[{"name":"University of Texas MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Popat","sequence":"additional","affiliation":[{"name":"The Royal Marsden National Health Service Foundation Trust","place":["London, UK"]},{"name":"The Institute of Cancer Research","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert F.","family":"Smit","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Christopoulos","sequence":"additional","affiliation":[{"name":"Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital","place":["Heidelberg, Germany"]},{"name":"Member of the German Center for Lung Research (DZL)","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Planchard","sequence":"additional","affiliation":[{"name":"Thoracic Group and International Centre for Thoracic Cancers","place":["Villejuif, France"]},{"name":"Paris-Saclay University","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Yoshida","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Zugazagoitia","sequence":"additional","affiliation":[{"name":"12 de Octubre Hospital","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[{"name":"Harbin Medical University Cancer Hospital","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Wilding","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim RCV GmbH & Co. KG","place":["Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00501-4"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-1040"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107992"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70272"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860313"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2204.0023"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.009"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco-24-02785"},{"key":"e_1_3_6_11_1","unstructured":"US Food and Drug Administration. Highlights of prescribing information. Enhertu (fam-trastuzumab deruxtecan-nxki). [cited 2025 Aug 12]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761139s032s035lbl.pdf"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01361"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112431"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100554"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116702"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00412-y"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01469-6"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.09.001"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.01.013"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.02.017"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2020.07.017"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv186"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.01.158"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-022-00884-z"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01113"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01323"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02245-z"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00297"},{"key":"e_1_3_6_29_1","unstructured":"US Food and Drug Administration. Meeting of the oncologic drugs advisory committee announcement 2022. 2022 Sep 22\u201323 [cited 2024 Nov 28]. Available from: https:\/\/web.archive.org\/web\/20230201132248\/https:\/\/www.fda.gov\/media\/164048\/download"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0306"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-4035"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01727"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2503704"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.09.1159"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Am2025-lb270"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.4641"},{"key":"e_1_3_6_37_1","volume-title":"Presented at the Marbach Castle Drug-Drug Interaction Workshop","author":"Funck C","year":"2025","unstructured":"Funck C, Wind S, Mahmoudi M, et al. Effect of zongertinib, a novel, irreversible tyrosine kinase inhibitor on the pharmacokinetics of dabigatran, rosuvastatin, metformin, and furosemide, in healthy male volunteers: an open-label, two-period, fixed-sequence crossover trial. Presented at the Marbach Castle Drug-Drug Interaction Workshop; \u00d6hningen, Germany; 2025 Jun 1\u20133."},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.06.025"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-03975-6"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2623059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737140.2026.2623059","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2026.2623059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:36:45Z","timestamp":1782913005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2026.2623059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,3]]}},"alternative-id":["10.1080\/14737140.2026.2623059"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2026.2623059","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}